Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
2018 ◽
Vol 20
(10)
◽
pp. 2408-2415
◽
2011 ◽
Vol 94
(2)
◽
pp. 217-224
◽
2013 ◽
Vol 13
(5)
◽
pp. 343-351
◽
2016 ◽
Vol 36
(5)
◽
pp. 640-648
◽
2012 ◽
Vol 28
(3)
◽
pp. 268-275
◽